
52:12
Does START funding help justifying supplemental Phase B funding (matching dollars)?

53:09
Charlie, can we get a copy of these charts?

53:59
Does START assist with the initial SBIR application?

54:06
Could you comment on the eligibility of life science companies for the START program?

54:49
What are MassVentures “rights” with respect to companies that receive START grants at the different levels?

54:53
What is the allowable use of funds under START? Is it mostly focused on business development activities versus R&D?

55:12
Does START take go-to-market timing into consideration for awarding the Grant? For example, certain bio-pharm products could take a few years to get to market. Does this affect ability to be selected this year?

55:25
jeff bussgang had a great article on company valuations, your opening slide had a comment that Science technology companies are typical underfunded. what do we need to have to breakout even if we have exciting science and a potential customer base

56:43
Are capital expenditures allowed in the START programs' funding?

58:50
What are things that judges look for when evaluating management (what are negatives)?

59:12
We are actively pursuing additional government sources for aspects of our technology development. Our use of the START funding would depend on whih of these other sources come through. Is it acceptable (and not considered negative) to have different possible uses of the START funds based upon our success with these additional government funding source?

59:28
Similar question- what about K12 edtech? (IES SBIR)

01:00:41
ie similar question to deep tech

01:04:31
What is the timeline for the use of funds?

01:04:52
Great thanks!

01:06:36
I we are fortunate enough to win Phase I and are notified in late April, can we pre-spend funds out of our own capital then reimburse ourselves for those expenses once we received the START funds in June.

01:07:25
Do the reviewers sign an NDA or confidentiality agreement with MassVentures?

01:09:45
We got one four years ago that has been extended because Covid interfered with the clinical trial. Can that qualify?

01:09:52
Can 30-50% of the start fund be used for a software license that is used for both R&D and business development?

01:12:34
Just to confirm, the START funding is for the platform and company growth, not for the specific product that the SBIR was for?

01:15:15
I missed the first 15 min. is application similar to last years?

01:16:42
thanks everyone for attending!